Rhythm Pharmaceuticals (RYTM) Return on Invested Capital (2022 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Return on Invested Capital of 0.01% for Q1 2026, up 6.0% year-over-year from 0.01% in Q1 2025, and down 10.88% quarter-over-quarter from 0.01% in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Return on Invested Capital (2022 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 5 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.
- Return on Invested Capital for Q1 2026 came in at 0.01%, up 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (up 6.0% YoY), and the FY2025 annual result was 0.02%, changed 0.0% from the prior year.
- Return on Invested Capital retreated to 0.01% in Q1 2026 per RYTM's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.01% in Q1 2022 and troughed at 0.29% in Q2 2025.
- A 5-year average of 0.06% and a median of 0.02% in 2024 frame the typical range for Return on Invested Capital.
- On a YoY basis, Return on Invested Capital climbed as much as 14 bps in 2025 and fell as far as 23 bps in 2025.
- A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2022, then fell by 27 bps to 0.01% in 2023, then sank by 1510 bps to 0.15% in 2024, then soared by 92 bps to 0.01% in 2025, then dropped by 11 bps to 0.01% in 2026.
- Business Quant data shows RYTM's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.03% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.01% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -0.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.29% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | -0.15% |
| Sep 30, 2024 | -0.11% |
| Jun 30, 2024 | -0.05% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Mar 31, 2022 | -0.01% |